Skip to content
CheckOrphan
  • Home
  • About Us
  • Team
  • Log In
  • News
    • All News
    • Finance
    • Treatment
    • People
  • Videos
  • Treatments
  • Clinical Trials
  • Access Programs
    • All Access Programs
  • Diseases
  • Events
  • Networks
  • Research
Main Menu

Subscribe for Free Newsletter

Email *

Type *

* Required Field
Email Marketing Services by Benchmark

Generate RSS

  1. Home
    2. /
  2. Clinical Trial
    3. /
  3. Study of REGN5668 Administered...

Study of REGN5668 Administered in Combination With Cemiplimab or REGN4018 in Adult Women With Recurrent Ovarian Cancer.

October 24, 2020checkorphan
Learn more about:
Fallopian tube cancer